Marie Hudson
Research Scientist, Rheumatology MD, MPH, FRCPC
Appointments
- Clinician-scientist, Jewish General Hospital and Lady Davis Institute
- Associate Professor, Department of Medicine, McGill University
Research Interests
-
Systemic autoimmune rheumatic diseases
Dr. Hudson received her MD from McGill University, where she completed her residency training in internal medicine and rheumatology. She subsequently obtained a Master’s degree in Public Health from Columbia University in New York, and then returned to McGill to pursue a post-doctoral fellowship in epidemiology. Dr. Hudson is a fellow of the Royal College of Physicians and Surgeons of Canada and has received the prestigious New Investigator Award from the Canadian Institutes of Health Research.
Dr. Hudson pursues research in systemic autoimmune rheumatic diseases. In particular, she is one of the founding members of the Canadian Scleroderma Research Group (CSRG), a CIHR-funded, multi-centre group of researchers that follows a cohort of over 1600 SSc patients across Canada. She has published landmark studies documenting the magnitude of impairment in health-related quality of life (HRQoL) with scleroderma. She is particularly interested in scleroderma lung disease, its natural history, its optimal treatment, and its impact on HRQoL. She is currently developing a novel translational and clinical research program focused on cellular therapies for SSc. Dr Hudson is also involved in a number of studies in other rheumatic diseases, including inflammatory myositis, rheumatoid arthritis and rheumatic-immune related adverse events resulting from cancer immunotherapy. She is the recipient of the 2011 Canadian Rheumatology Association Young Investigator Award.Learn more
Recent News Coverage
OPTIKNEE – International team working to prevent knee osteoarthritis after knee injury
OPTIKNEE, led by Arthritis Research Canada, Research Scientist Dr. Jackie Whittaker, is an international group of over 40 scientists, patients and health care professionals working to prevent knee osteoarthritis after knee injury.
Medication used to lower cholesterol does not affect those with pre-radiographic knee osteoarthritis
A study has shown that the use of statins, traditionally utilized to lower cholesterol, is neither harmful nor beneficial to those with knee osteoarthritis.
Research Links TNF Biologics Use with Risk of Multiple Sclerosis
Researchers warn people with rheumatic diseases who have a family history of multiple sclerosis should not be taking anti-TNFα biologics after study reveals 105% increased risk of developing MS among this group of people.
Conducting Life-Changing Arthritis Research from Coast to Coast
Arthritis Research Canada expands with a new centre at Dalhousie University in Halifax, Nova Scotia and welcomes two new scientists to its cross-Canada team.
Hayley’s Story
Hayley has lived with juvenile idiopathic arthritis for almost half of her life. Now, she’s in medical school and considering how arthritis research has directly impacted her quality of life.
Computer Simulation Study Helps Assess Interventions to Reduce the Burden of Low Back Pain
A study conducted by Arthritis Research Canada sought to examine the impact of three strategies intended to reduce the burden of lower back pain (LBP) along with a secondary goal of determining the usefulness of a new microsimulation modeling software, SimYouLate.
Reducing Body Fat helps to Minimize the Risk of Developing Gout, Especially in Women
Excess weight and genetics have been linked to an increased risk of gout, according to a recent study conducted by Arthritis Research Canada.
Social Factors that Influence Health at Root of Racial Disparities in Gout
Gout is more common in Black men and women in the United States than in white men and women, according to a new Arthritis Research Canada study. However, researchers suggest this finding is tied to social and lifestyle factors that impact health – like poverty, diet, weight etc. – rather than genetics.
Arthritis Research Canada Launches #EscapeArthritis Awareness Campaign
September is Arthritis Awareness Month. This year, we’re raising awareness about how arthritis research helps people living with different types of arthritis find solutions to the challenges raised by their diseases so they can #EscapeArthritis.
Hydroxychloroquine Deemed Safe for People Newly Diagnosed with Rheumatoid Arthritis and Lupus
Arthritis Research Canada researchers find that people with autoimmune rheumatic diseases and transplant recipients face a heightened risk of complications from COVID-19.
